The Gastrointestinal Motility Therapy Apparatus ecosystem comprises a defined set of upstream, midstream, and downstream actors that collectively enable the design, production, distribution, and clinical application of motility‑modulating devices. Upstream, raw‑material and component suppliers provide biocompatible polymers, micro‑actuators, and sensor elements that meet medical‑device standards. Midstream participants—technology providers, OEM manufacturers, and system integrators—assemble these inputs into calibrated therapy platforms, embed software controls, and obtain regulatory clearances. Downstream, distributors, service organizations, and health‑care providers deliver the finished apparatus to hospitals, specialty clinics, and home‑care settings. Value is captured through engineering differentiation, compliance milestones, and service contracts, while revenue flows from device sales, leasing, and post‑sale support. Intellectual‑property licensing and data‑service subscriptions further extend the revenue base.